Literature DB >> 27323138

Relationship between estrogen receptor 1 gene polymorphisms and postmenopausal osteoporosis of the spine in Chinese women.

D P Shang1, H Y Lian1, D P Fu1, J Wu1, S S Hou1, J M Lu1.   

Abstract

The purpose of this study was to evaluate single nucleotide polymorphism (SNP) variants of the estrogen receptor 1 gene (ESR1) at rs2234693 and rs9340799, as well as to investigate the relationship between ESR gene polymorphisms and postmenopausal osteoporosis (OP) of the spine in Chinese women. We recruited 198 postmenopausal women with OP and 276 healthy women between May 2012 and September 2015 in Zhongshan Hospital. Dual energy x-ray absorptiometry was used to measure the bone mineral density (BMD) of the lumbar vertebrae in all subjects. In addition, PCR-restriction fragment length polymorphism based analysis was conducted to identify the genotypes of ESR1. The distribution of ESR1 in the osteoporosis group and the control group was determined; the relationship between ESR polymorphisms and BMD was analyzed. The distributions of BMD were: TT < TC < CC, GG < AG < AA. The TT, TTGG, and TCGG genotypes were found to be lower as compared to the other genotypes. Stratified analysis suggested that the TT genotype and the combined genotypes TTGG and TCGG were significantly higher in the OP group as compared to the control group (P < 0.01). Therefore, ESR1 polymorphisms at rs2234693 and rs9340799 may be associated with OP, and could be used as markers to screen those with high risks to postmenopausal OP in Chinese women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27323138     DOI: 10.4238/gmr.15028106

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  8 in total

1.  Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis.

Authors:  Qi Fei; Xiaodong Bai; Jisheng Lin; Hai Meng; Yong Yang; Ai Guo
Journal:  Int J Mol Med       Date:  2018-03-19       Impact factor: 4.101

2.  ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease.

Authors:  Iwona Krela-Kaźmierczak; Marzena Skrzypczak-Zielińska; Marta Kaczmarek-Ryś; Michał Michalak; Aleksandra Szymczak-Tomczak; Szymon T Hryhorowicz; Marlena Szalata; Liliana Łykowska-Szuber; Piotr Eder; Kamila Stawczyk-Eder; Maciej Tomczak; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  J Clin Med       Date:  2019-08-24       Impact factor: 4.241

3.  Estrogen and estrogen receptors in kidney diseases.

Authors:  Hao-Yang Ma; Shuang Chen; Yang Du
Journal:  Ren Fail       Date:  2021-01-01       Impact factor: 2.606

4.  Investigation of anti-osteoporosis mechanisms of Rehmanniae Radix Preparata based on network pharmacology and experimental verification.

Authors:  Li Ou; Wenqian Kang; Ziyi Liang; Feng Gao; Taiwei Dong; Peifeng Wei; Min Li
Journal:  J Orthop Surg Res       Date:  2021-10-14       Impact factor: 2.359

Review 5.  Associations between ERα/β gene polymorphisms and osteoporosis susceptibility and bone mineral density in postmenopausal women: a systematic review and meta-analysis.

Authors:  Heping Zhu; Jiannong Jiang; Qiang Wang; Jun Zong; Liang Zhang; Tieliang Ma; Youjia Xu; Leiyan Zhang
Journal:  BMC Endocr Disord       Date:  2018-02-20       Impact factor: 2.763

Review 6.  Associations between VDR Gene Polymorphisms and Osteoporosis Risk and Bone Mineral Density in Postmenopausal Women: A systematic review and Meta-Analysis.

Authors:  Liang Zhang; Xin Yin; Jingcheng Wang; Daolinag Xu; Yongxiang Wang; Jiandong Yang; Yuping Tao; Shengfei Zhang; Xinmin Feng; Caifeng Yan
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

7.  A Network Pharmacology Approach to Determine the Active Components and Potential Targets of Curculigo Orchioides in the Treatment of Osteoporosis.

Authors:  Nani Wang; Guizhi Zhao; Yang Zhang; Xuping Wang; Lisha Zhao; Pingcui Xu; Dan Shou
Journal:  Med Sci Monit       Date:  2017-10-27

8.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.

Authors:  Lang Yang; Liuyi Fan; Kexin Wang; Yupeng Chen; Lan Liang; Xuemei Qin; Aiping Lu; Peng Cao; Bin Yu; Daogang Guan; Junxiang Peng
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.